Baird Medical, a medical technology company, agreed to go public via a merger with ExcelFin Acquisition, a special purpose acquisition company, in a $370m deal. "The business combination with ExcelFin marks a significant milestone for Baird Medical. We believe ExcelFin's partnership and international connections will provide us with the necessary resources to further expand our presence in the global market, accelerate our growth trajectory, and continue delivering innovative medical solutions to patients worldwide. We are confident that this combination will unlock opportunities and drive our vision of transforming healthcare through advanced, minimally invasive treatments," Haimei Wu, Baird Medical Founder and CEO.